Envisia Therapeutics, Inc.

Envisia Therapeutics, Inc.

Envisia Therapeutics, Inc.

Overview
Date Founded

2013

Headquarters

419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals
Medical Support Services
Holding Companies

Company Description

Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.

Website

http://envisiatherapeutics.com

Contact Data
Trying to get in touch with decision makers at Envisia Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Business Wire
February 9, 2021
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire
November 17, 2020
Veracyte Announces New General Manager Structure to Advance Global Expansion; John Hanna appointed GM, endocrinology, breast cancer and lymphoma;; Morten Frost to join company as GM, pulmonology
Business Wire
October 14, 2020
Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020
Business Wire
August 7, 2020
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire
August 5, 2020
Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases; ePosters presented during ATS 2020 Virtual conference

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Benjamin R. Yerxa

Co-Founder

Gary Phillips

Executive Chairman

Daria Stoltz

Clinical Research Director

Stacey Pittman

Vice President-Clinical Operations

Kristin Blackwell

Regulatory Affairs Manager

Erica Deibert

Scientist III

Board of Directors
William E. Yelle

Chief Executive Officer & Director at ALDEA Pharmaceuticals, Inc.

Trending People
Migdal Mtf (00) Fix Rate Govt. Synthetic Dur. 2-5 Yrs. (ils)
Wednesday April 21, 2021 Thomson Medical Group (A50:10.60c) sinks 4.5%, underper... - News Bites - Asia: Singapore
ASML Holding NV
Technology Sector Update for 04/21/2021: ASML, ERIC, TEL, XLK, SOXX - Nasdaq
Canadian National Railways
More Businesses Are Standing for Justice; DealBook Newsletter - The New York Times
Senate Committee on Finance
Sen. Wyden Statement at Finance Committee Hearing on Inequality in the U.S. Tax... - Targeted News Service
Kansas City Southern
More Businesses Are Standing for Justice; DealBook Newsletter - The New York Times
Trending Organizations
Migdal Mtf (00) Fix Rate Govt. Synthetic Dur. 2-5 Yrs. (ils)
Wednesday April 21, 2021 Thomson Medical Group (A50:10.60c) sinks 4.5%, underper... - News Bites - Asia: Singapore
ASML Holding NV
Technology Sector Update for 04/21/2021: ASML, ERIC, TEL, XLK, SOXX - Nasdaq
Canadian National Railways
More Businesses Are Standing for Justice; DealBook Newsletter - The New York Times
Senate Committee on Finance
Sen. Wyden Statement at Finance Committee Hearing on Inequality in the U.S. Tax... - Targeted News Service
Kansas City Southern
More Businesses Are Standing for Justice; DealBook Newsletter - The New York Times
Paths to Envisia Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Envisia Therapeutics, Inc.
Recent Transactions
Details Hidden

Envisia Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Envisia Therapeutics, Inc. raised money in a private placement transaction

Investors
Details Hidden
Wakefield Group LLC

Wakefield Group invests in companies located in United states. The firm focuses on growth capital investments in companies in the technology, healthcare, business services and media sectors. It provides financing for early stage capital requirements with an investment size in the range of $1 - $5 million per transaction and also provides follow-on capital financing.

Details Hidden
Morningside Group Ltd.

Morningside Group is an active, long-term manager which invests in a range of sectors including telecom and Internet, machinery manufacturing, high-tech, media, telecommunications, life sciences and education sectors. They invets in companies in North America, Europe and Asia Pacific, with a particular focus on China.The firm seeks to create value in their investee companies, partnering with managementto develop strategy, build the necessary management infrastructure, access domestic and international growth opportunities and achieve optimal investment exit through capital market operations.

Details Hidden
New Enterprise Associates, Inc.

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Envisia Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Envisia Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Envisia Therapeutics, Inc..